KYGEVVI™ (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 ...

Bitcoin price faces volatility around $101K. Our Bitcoin price prediction expects BTC’s price to reach $160K by the end of ...

The Berkshire Innovation Center's plans for an optics tech hub have been boosted by $5.2 million from the state. On Thursday, ...

Chinese miners vandalise one of Zimbabwe’s most iconic natural reserves – CITEZW By Leopold Munhende THE future of ...

The NZD/USD pair posts modest losses near 0.5660 during the early European session on Thursday. The New Zealand Dollar (NZD) ...

Polygon, an Ethereum side chain and layer two scaling solution, has experienced substantial uptake by enterprises and ...

A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...

November 3, 2025Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAPFirst European patient expected to be enrolled in 4Q ...

At the front of the vehicle, there are no major openings in the top half of the fascia, confirming that this new baby Defender will be electric. Fake body cladding and trippy camou make it difficult ...

The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (the "Company"), announced that Nanoviricides CEO Dr Anil Diwan joined Steve Darling from ...